American Society of Hematology

Free CME Summit on Myelodysplastic Syndromes

Improving MDS Outcomes From Diagnosis to Treatment: A Multidisciplinary Approach

There are many complexities associated with myelodysplastic syndromes (MDS) that a multispecialty team must address as a clinical-care unit. These complexities include obtaining adequate bone marrow specimens, identification and classification of MDS, the comorbidity rate of MDS patients, and the decision-making process for treatment. To address educational gaps associated with these complexities, ASH, the American Society for Clinical Pathology (ASCP), and the France Foundation have designed comprehensive MDS-directed educational summits that feature live events designed by world-class subject matter experts.

Participants of these summits will actively engage in multidisciplinary, interactive small-group activities, including case-based tumor board discussions and four break-out sessions on:

  • Assessing low- or high-grade MDS
  • Acquiring of morphologic mimics
  • Applying the prognostic scoring system to cytogenetics
  • Identifying the new role of molecular testing

Who should attend?

  • Hematologists
  • Medical Oncologists
  • Hematopathologists
  • Pathologists
  • Pathologists' Assistants
  • Hematology and Oncology Nurse Practitioners
  • Physician Assistants
  • Medical Laboratory Scientists

Dates and Locations

Registration is free for these events.

October 4, 2017
Boston, MA

Loews Boston Hotel
Register now

October 18, 2017
Dallas, TX

Dallas Marriott Suites Medical/Market Center
Register now

November 8, 2017
Los Angeles, CA

The Westin Bonaventure Hotel & Suites
Register now

For more information on registration and accreditation or to view the schedule and program, please visit the summit website.

back to top